The successful design and development of medical diagnostic point of care or clinical microarrays can be among the most daunting of challenges for both startups and incumbent companies alike. Navigating this challenging path requires significant experience and multidisciplinary expertise. With an introduction from SCHOTT MINIFAB’s Dr. James Downs, in this 30-minute presentation, Dr. Tamma Kaysser-Kranich will discuss 9 key factors critical to diagnostic microarray development for the IVD market.
The discussion will review detection methodologies, substrate types, active surface chemistries, biological detector types, as well as critical microarray design considerations and features. Dr. Kaysser-Kranich will clarify how these factors, through an integrated approach to early design, are key to successful product development, and in turn lead to fewer downstream product design changes and a more rapid path to product launch.
Specifically, participants can expect to learn:
- 9 key factors critical to molecular microarray development
- The value that integrated approach to the early design phase plays in the success of product development
WATCH REPLAY EVENT The webinar had some buffering issues effecting the audio capture. Click here for a pre-recorded session.
Tamma Kaysser-Kranich
VP, Chief Technology Officer
Tamma Kaysser-Kranich has been involved in research and diagnostic microarray development, design, product launch, and production for more than 20 years. Her background includes a B.S. in Biochemistry from UC Davis, a Ph.D. in biochemistry from University of Illinois, Urbana-Champaign, and a post doctorate at Jackson Laboratories. She has been involved in microarray product design and production at Motorola Life Sciences, Amersham Biosciences, GE Healthcare, Applied Microarrays, now a company of SCHOTT MINIFAB, where she is VP, Chief Technology Officer.
James Downs
Business Development Manager US & Europe
Leveraging a rich 20+ year international career across a spectrum of the biopharmaceutical and medical device chains, James is passionate about exploring innovative solutions to help companies that are developing highly complex point-of-care and clinical diagnostic cartridges and components. James’ background includes a B.S. in Economics from the Univ. of Southern MS and an MBA and PhD in Economics from HHL Leipzig Graduate School of Business. His career spans management roles with Pfizer Inc, leading multiple medical device startups and now SCHOTT MINIFAB where is his responsible for business development.
